Summary
We tested a new schedule for follow up of anthracycline therapy using radionuclide angiography (RNA) in our hospital: just suspend the treatment for one cycle when the absolute LVEF <50% (or 30% if the initial LVEF was already abnormal) or if a drop > 10% occured. Anthracycline treatment could then be restarted if the LVEF was retored, RNA being then performed at the beginning of each cycle. A remission was obtained in 25 cases. A complete remission could even be obtained in a patient whose LVEF was <50% during treatment.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Borow KM, Henderson IC, Neuman A. Assessment of left ventricular contractility in patients receiving doxorubicin. Ann Intern Med. 1983; 99: 750–756.
Schwartz RG, McKenzie MB, Alexander J. Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Am J. Med. 1987; 82: 1109–1118.
Hortobagyi GN, Frye D, Budzar U. Decreased cardiac toxicity of doxorubicin administered by continuous intravenous infusion in combination chemotherapy for metastatic breast carcinoma. Cancer 1989; 63: 37–45.
Choi BW, Berger HJ, Schwartz PE. Serial radionuclide assessment of doxorubicin cardiotoxicity in cancer patients with abnormal baseline resting left ventricular performance. Am Heart J1983; 106: 638–643.
Legha SS, Benjamine RS, Mackay B. Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. Ann Intern Med 1982; 96: 133–139.
Dardir MH, Ferrans VJ, Mikhael SY. Cardiac morphologic and functional changes induced by epirubicin chemotherapy. J Clin Oncol 1989; 7: 947–958.
Schwartz RG, Zaret B. Diagnosis and treatment of drug induced myocardial disease. In: Muggia FC, Speyer JL, eds. Cardiotoxicity of anticancer therapy. 1990.
Bristow MR, Mason JW, Bilingham ME, Daniels JR. Dose-effect and structure-function relationship in doxorubicin cardiomyopathy. Am Heart J 1981; 102: 709718.
Druck MN, Gulenchyn KY, Evans WK. Radionuclide angiography and endomyocardial biopsy in the assessment of doxorubicin cardiotoxicity. Cancer 1984; 53: 1667–1674.
Pauwels EKJ, Horning SJ, Goris ML. Sequential equilibrium gated radionuclide angiocardiography for the detection of doxorubicin cardiotoxicity. 1983; 1: 83–87.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Basel AG
About this chapter
Cite this chapter
Patrois, F. et al. (1997). Follow-Up of Cardiac Toxicity of Anthracycline Chemotherapy with Equilibrium Radionuclide Angiography. In: Bergmann, H., Kroiss, A., Sinzinger, H. (eds) Radioactive Isotopes in Clinical Medicine and Research. Advances in Pharmacological Sciences. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-7772-5_77
Download citation
DOI: https://doi.org/10.1007/978-3-0348-7772-5_77
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-7774-9
Online ISBN: 978-3-0348-7772-5
eBook Packages: Springer Book Archive